Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.62 |
| ▸ | ATM | Q13315 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 6/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | NAAA | Q02083 | 1/20 | 0.54 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | RAD52 | P43351 | 1/20 | 0.46 |
| ▸ | APP | P05067 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4369309 | 0.98 | HCAR2 (0.63) | HCAR2ATMTSHRHPGDNAAA | |
| SCHEMBL4364153 | 0.98 | HCAR2 (0.63) | HCAR2ATMTSHRHPGDNAAA | |
| SCHEMBL8379400 | 0.98 | HCAR2 (0.63) | HCAR2ATMTSHRHPGDNAAA | |
| SCHEMBL8376821 | 0.98 | HCAR2 (0.63) | HCAR2ATMTSHRHPGDNAAA | |
| SCHEMBL4371063 | 0.98 | HCAR2 (0.63) | HCAR2ATMTSHRHPGDNAAA | |
| SCHEMBL1245209 | 0.98 | HCAR2 (0.63) | HCAR2ATMTSHRHPGDNAAA | |
| SCHEMBL5238456 | 0.98 | HCAR2 (0.63) | HCAR2ATMTSHRHPGDNAAA | |
| SCHEMBL8390518 | 0.98 | HCAR2 (0.63) | HCAR2ATMTSHRHPGDNAAA | |
| SCHEMBL697992 | 0.98 | HCAR2 (0.63) | HCAR2ATMTSHRHPGDNAAA | |
| SCHEMBL5239452 | 0.98 | HCAR2 (0.63) | HCAR2ATMTSHRHPGDNAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105307661-A | 4'-azido, 3'-deoxy-3'-fluoro substituted nucleoside derivatives | RIBOSCIENCE LLC | 2016-02-03 | — | — | CN | claimed |
| US-20200071617-A1 | LIQUID CRYSTAL DISPLAY ELEMENT | DIC CORPORATION (JP) | 2020-03-05 | — | — | US | disclosed |
| EP-3057574-A1 | DRUG FOR PREVENTING AND/OR TREATING POLYCYSTIC KIDNEY DISEASE | Otsuka Pharmaceutical Co., Ltd. (JP) | 2016-08-24 | — | — | EP | disclosed |
| CN-105307661-A | 4'-azido, 3'-deoxy-3'-fluoro substituted nucleoside derivatives | RIBOSCIENCE LLC | 2016-02-03 | — | — | CN | disclosed |
| WO-2015056805-A1 | DRUG FOR PREVENTING AND/OR TREATING POLYCYSTIC KIDNEY DISEASE | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2015-04-23 | — | — | WO | disclosed |
| EP-2854815-A1 | DRUG FOR PREVENTING AND/OR TREATING POLYCYSTIC KIDNEY DISEASE | Otsuka Pharmaceutical Co., Limited (JP) | 2015-04-08 | — | — | EP | disclosed |
| WO-2013180310-A1 | DRUG FOR PREVENTING AND/OR TREATING POLYCYSTIC KIDNEY DISEASE | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-12-05 | — | — | WO | disclosed |
| EP-1459742-B9 | Agent for prophylaxis and treatment of asthenopia and pseudomyopia | SENJU PHARMA CO (JP) | 2012-05-02 | — | — | EP | disclosed |
| EP-2423199-A1 | Substituted imidazoles and their use as pesticides | Pfizer Limited (GB) | 2012-02-29 | — | — | EP | disclosed |
| EP-1459742-B1 | Agent for prophylaxis and treatment of asthenopia and pseudomyopia | SENJU PHARMA CO (JP) | 2011-10-12 | — | — | EP | disclosed |
| US-5306808-A | Endothelin derivatives | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-04-26 | — | — | US | disclosed |
| EP-0380144-B1 | Process for producing optically active benzene-sulfonamide derivatives | YAMANOUCHI PHARMA CO LTD (JP) | 1994-01-19 | — | — | EP | disclosed |
| EP-0547317-A1 | Endothelin antagonists | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-06-23 | — | — | EP | disclosed |
| EP-0523543-A1 | Chiral piperazine derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1993-01-20 | — | — | EP | disclosed |
| EP-0499266-A1 | Endothelin antagonist | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1992-08-19 | — | — | EP | disclosed |
| EP-0470256-A1 | PEPTIDE DERIVATIVES AND PRODUCTION THEREOF | Takeda Chemical Industries, Ltd. (JP) | 1992-02-12 | — | — | EP | disclosed |
| WO-1991013089-A1 | PEPTIDE DERIVATIVES AND PRODUCTION THEREOF | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1991-09-05 | — | — | WO | disclosed |
| EP-0257787-B1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE BENZENE-SULFONAMIDE DERIVATES | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1991-04-17 | — | — | EP | disclosed |
| EP-0380144-A1 | Process for producing optically active benzene-sulfonamide derivatives | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1990-08-01 | — | — | EP | disclosed |
| EP-0257787-A1 | Process for producing optically active benzene-sulfonamide derivates | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1988-03-02 | — | — | EP | disclosed |